Traditional Knowledge and Molecular Evidence of Medicinal Plants for Multi-Target Dengue Therapy: A Review
Multi-Target Plant Therapeutics for Dengue
-
Mohammed Anas
Department of Biotechnology, Gandhi Institute of Engineering and Technology University, Gunupur, Odisha-765022, India AND BRIC-Institute of Life Sciences (ILS), Bhubaneswar, Odisha, India
-
Farhat Jahan
ICAR-Central Rice Research Institute (ICAR-CRRI), Cuttack-753006, Odisha, India AND Department of Botany, Ravenshaw University, Cuttack-753003, Odisha, India
Keywords:
Antiviral, Dengue, Ethnomedicine, Immunomodulation, PhytotherapyAbstract
Dengue fever continues to intensify as a major global public health challenge, driven by climate change, rapid urbanization, and expanding vector habitats, while the absence of a universally safe and effective antiviral therapy remains a critical limitation. Unlike conventional single-target antivirals, plant-based interventions offer a multi-target therapeutic strategy capable of simultaneously inhibiting viral replication, modulating immune dysregulation, reducing oxidative stress, stabilizing endothelial function, enhancing platelet recovery, and contributing to vector control. A wide range of phytochemicals, including flavonoids, alkaloids, tannins, polyphenols, polysaccharides, and bioactive enzymes, have been reported to interact with key dengue viral proteins such as NS2B-NS3 protease and NS5 RNA-dependent RNA polymerase, while also regulating host inflammatory and immunological pathways. Integration of ethnopharmacological data with molecular docking, network pharmacology, and preclinical studies provides mechanistic validation for traditionally used plants, particularly Carica papaya, Andrographis paniculata, and Tinospora cordifolia. Additionally, analysis of plant diversity, parts used, phytochemical classes, and conservation status highlights both therapeutic promise and sustainability concerns. Despite promising in-vitro and in-silico evidence, clinical translation remains constrained by lack of standardized formulations, limited in-vivo validation, and insufficient large-scale clinical trials. This review comprehensively integrates epidemiological trends, dengue virus biology, pathogenesis, traditional knowledge, and modern molecular evidence to evaluate the therapeutic potential of medicinal plants in dengue management. Overall, this review underscores medicinal plants as evidence-based, multi-target candidates for next-generation dengue therapeutics, offering a sustainable and affordable pathway to mitigate the escalating global dengue burden.
Downloads
References
References
Kausar S, Khan FS, Rehman MIMU, Akram M, Riaz M, Rasool G, et al. A review: Mechanism of action of antiviral drugs. Int J Immunopathol Pharmacol. 2021; 35:20587384211002621.
Balloux F, van Dorp L. Q&A: What are pathogens, and what have they done to and for us? BMC Biol. 2017;15(1):1–6.
Taylor NM, Leiman PG. Editorial overview: Virus structure and expression. Curr Opin Virol. 2020;45:iii–v.
Aktar F, Karim A, Chowdhury RN, Sultana SA, Amran MS. Recent advances in dengue, viral hepatitis, and HIV infections and related management strategies. Avicenna J Med Biochem. 2024;12(2):172–187.
Kularatne SAM, Dalugama C. Dengue infection: Global importance, immunopathology and management. Clin Med. 2022;22(1):9–13.
World Health Organization. Dengue – Global situation. Disease Outbreak News. 2023.
Chong HY, Leow CY, Abdul Majeed AB, Leow CH. Flavivirus infection-A review of immunopathogenesis, immunological response, and immunodiagnosis. Virus Res. 2019;274:197770.
Zoladek J, Nisole S. Mosquito-borne flaviviruses and type I interferon: Catch me if you can! Front Microbiol. 2023;14:1257024.
Mustafa MS, Rasotgi V, Jain S, Gupta VJ. Discovery of fifth serotype of dengue virus (DENV-5): A new public health dilemma in dengue control. Med J Armed Forces India. 2015;71(1):67–70.
Roy S, Bhattacharjee S. Dengue virus: Molecular biology and immune response. J Clin Virol. 2021;144:104–112.
Centers for Disease Control and Prevention. 2025 report (Internet). Available from: https://www.cdc.gov.
Brady OJ, Gething PW, Bhatt S, et al. Refining the global spatial limits of dengue virus transmission by evidence-based consensus. PLoS Negl Trop Dis. 2012;6(8):e1760.
Yang X, Quam MBM, Zhang T, Sang S. Global burden for dengue and the evolving pattern in the past 30 years. J Travel Med. 2021;28:taab146.
Pierson TC, Diamond MS. The continued threat of emerging flaviviruses. Nat Microbiol. 2020;5:796–812.
Shepard DS, Undurraga EA, Halasa YA, Stanaway JD. The global economic burden of dengue: A systematic analysis. Lancet Infect Dis. 2016;16(8):935–941.
Messina JP, Brady OJ, Golding N, Kraemer MUG, Wint GRW, Ray SE, et al. The current and future global distribution and population at risk of dengue. Nat Microbiol. 2019;4:1508–1515.
World Health Organization. Dengue – Global situation. Disease Outbreak News. 2024.
Torto B, Tchouassi DP. Chemical ecology and management of dengue vectors. Annu Rev Entomol. 2024;69(1):159–182.
Qadir MI, Abbas K, Tahir M, Irfan M, Raza Bukhari SF, Ahmed B, et al. Dengue fever: Natural management. Pak J Pharm Sci. 2015;28(2):123–128.
Shawon SR, Hamid MKI, Ahmed H, Khan SA, Dewan SMR. Dengue fever in hyperglycemic patients: An emerging public health concern. Health Sci Rep. 2024;7(10):e70144.
La Russa VF, Innis BL. Mechanisms of dengue virus-induced bone marrow suppression. J Infect Dis. 1995;171(4):1051–1054.
Carlos CC, Oishi K, Cinco MT, Mapua CA, Inoue S, Cruz DJ, et al. Comparison of clinical features and hematologic abnormalities between dengue fever and dengue hemorrhagic fever among children in the Philippines. Am J Trop Med Hyg. 2005;73(2):435–440.
Oishi K, Inoue S, Cinco MT, Dimaano EM, Alera MT, Alfon JA, et al. Correlation between increased platelet-associated IgG and thrombocytopenia in secondary dengue virus infections. J Med Virol. 2003;71(2):259–264.
Wang S, He R, Patarapotikul J, Innis BL, Anderson R. Antibody-enhanced binding of dengue-2 virus to human platelets. Virology. 1995;213(1):254–257.
Halstead SB. Pathogenesis of dengue: Challenges to molecular biology. Science. 1988;239(4839):476–481.
Sangkawibha N, Rojanasuphot S, Ahandrik S, Rojanaphan T. Risk factors in dengue shock syndrome: The 1980 Rayong outbreak. Am J Epidemiol. 1984;120(5):653–669.
Burke DS, Nisalak A, Johnson DE, Scott RM. A prospective study of dengue infections in Bangkok. Am J Trop Med Hyg. 1988;38(1):172–180.
Rosen L. Dengue in Greece in 1927 and 1928 and the pathogenesis of dengue hemorrhagic fever. Am J Trop Med Hyg. 1986;35(3):642–653.
Libraty DH, Endy TP, Houng HS, Green S, Kalayanarooj S, Suntayakorn S, et al. Differing influences of virus burden and immune activation on disease severity in secondary dengue-3 virus infections. J Infect Dis. 2002;185(9):1213–1221.
Yang J, Mosabbir AA, Raheem E, Hu W, Hossain MS. Demographic characteristics, clinical symptoms, and biochemical markers in severe dengue. PLoS Negl Trop Dis. 2023;17(3):e0011161.
Lee TH, Lee LK, Lye DC, Leo YS. Current management of severe dengue infection. Expert Rev Anti Infect Ther. 2017;15(1):67–78.
Hermann LL, Gupta SB, Manoff SB, Kalayanarooj S, Gibbons RV, Coller BAG. Advances in the understanding, management, and prevention of dengue. J Clin Virol. 2015;64:153–159.
POWO. Plants of the World Online (Internet). Royal Botanic Gardens, Kew; 2025. Available from: http://www.plantsoftheworldonline.org/
Hasani SJ, Sgroi G, Esmaeilnejad B, Nofouzi K, Mahmoudi SS, Shams N, et al. Recent advances in the control of dengue fever using herbal and synthetic drugs. Heliyon. 2025;11(3):e41939.
Ganguly P, Mandal SK, Mondal P, Sen DJ. Medicinal plants effective against dengue fever in India: A brief review. J Biochem Phytomed. 2024;3(1):14–17.
Nur S, Amin MR, Hossain MA. Evaluation of anti-dengue activity of selected medicinal plants: A comprehensive review. J Ethnopharmacol. 2025;289:115–123.
Tan KS, Pippen R. Inhibition of dengue virus NS3 protease by panduratin A from Boesenbergia rotunda. J Ethnopharmacol. 2006;105(3):358–361.
World Health Organization. Dengue and severe dengue (Internet). 2013. Available from: https://www.who.int/news-room/fact-sheets/detail/dengue-and-severe-dengue
Gao Z, Zhang Y, Yang Y, Xu M, Liao P, He W, et al. Dengue virus infections among blood donors in Guangxi of China, 2013–2014. Transfus Med. 2018;28(3):236–242.
Guo C, Zhou Z, Wen Z, Liu Y, Zeng C, Xiao D, et al. Global epidemiology of dengue outbreaks in 1990–2015: A systematic review and meta-analysis. Front Cell Infect Microbiol. 2017;7:317.
Veena S. Larvicidal activity of Pimpinella anisum essential oil against Aedes aegypti. Int J Mosq Res. 2018;5(1):01–04.
Bhat TK, Sharma OP, Dawra RK. Larvicidal activity of some plant extracts against Aedes aegypti. J Entomol Zool Stud. 2015;3(2):193–197.
Casades-Martí L, Frías M, Delacour S, Ruiz-Fons F. Confirmed presence of Aedes (Rusticoidus) refiki Medschid, 1928 in a continental dry Mediterranean peri-urban environment in south-central Spain. BMC Zool. 2022;7(1):21.
Klawikkan N, Nukoolkarn V, Jirakanjanakit N. Anti-dengue activity of Flagellaria indica leaf extracts. Thai J Phytopharm. 2010;17(2):1–9.
Nedjadi T, El-Kafrawy S, Sohrab SS, Desprès P, Damanhouri G, Azhar E. Tackling dengue fever: Current status and challenges. Virol J. 2015;12:1–11.
Chaithong U, Choochote W, Kamsuk K, Jitpakdi A, Tippawangkosol P, Chaiyasit D, et al. Larvicidal effect of pepper plants on Aedes aegypti (L.) (Diptera: Culicidae). J Vector Ecol. 2006;31(1):138–144.
Govindarajan M, Rajeswary M, Arivoli S, Tennyson S, Benelli G. Larvicidal and repellent potential of Zingiber nimmonii essential oil: An eco-friendly tool against mosquito vectors. Parasitol Res. 2016;115:1807–1816.
Arivoli S, Samuel T. Bioefficacy of Citrullus colocynthis (L.) Schrad (Cucurbitaceae) whole plant extracts against Anopheles stephensi, Aedes aegypti and Culex quinquefasciatus (Diptera: Culicidae). Int J Curr Res. 2011;3(4):296–304.
Samidurai K, Saravanakumar A. Larvicidal and repellent activities of Pemphis acidula leaf extracts against Aedes aegypti. J Vector Borne Dis. 2011;48(2):115–118.
National Centre for Biotechnology Information (Internet). 2025. Available from: https://www.ncbi.nlm.nih.gov/
Rathnayake H, Weerasinghe S, Silva N. 5,7-Dimethoxycoumarin from Micromelum minutum exhibits anti-dengue activity. J Nat Med. 2020;74(4):789–797.
Saravanan S, Sivasankar P, Muthu K. Apiofuranoside from Andrographis paniculata shows anti-dengue activity. Nat Prod Res. 2021;35(4):678–682.
Zandi K, Teoh BT, Sam SS, Wong PF, Mustafa MR, AbuBakar S. Novel antiviral activity of baicalein against dengue virus. BMC Complement Altern Med. 2012;12:214.
Moghaddam E, Teoh BT, Sam SS, Lani R, Hassandarvish P, Chik Z, et al. Baicalin, a metabolite of baicalein with antiviral activity against dengue virus. Sci Rep. 2014;4(1):5452.
Shrivastava S, Sharma P, Gupta A. Carpaine from Carica papaya: A promising agent for platelet enhancement in dengue. Phytomedicine. 2022;98:153–160.
Whitby K, Pierson TC, Geiss B, Lane K, Engle M, Zhou Y, et al. Castanospermine, a potent inhibitor of dengue virus infection in vitro and in vivo. J Virol. 2005;79(14):8698–8706.
Low JG, Sung C, Wijaya L. Efficacy and safety of celgosivir in patients with dengue fever. J Infect Dis. 2014;209(6):873–879.
Cano-Lamadrid M, Girón-Hernández J, López-Lluch D. Tannins as antiviral agents against dengue virus. Phytochem Rev. 2020;19(2):305–318.
Shoyshob TZ, Heya IA, Afrin N, Enni MA, Asha IJ, Moni A, et al. Protective mechanisms of Carica papaya leaf extract. Immuno. 2024;4(4):629–645.
Vázquez-Calvo Á, Jiménez de Oya N, Martín-Acebes MA, Garcia-Moruno E, Saiz JC. Antiviral properties of the natural polyphenols delphinidin and epigallocatechin gallate against the flaviviruses West Nile virus, Zika virus, and dengue virus. Front Microbiol. 2017;8:1314.
Dewi DYS, Ginting CN, Chiuman L, Girsang E, Handayani RAS, Widowati W. Potentials of rose (Rosa damascena) petals and receptacles extract as antioxidant and antihyaluronidase. Pharmaciana. 2020;10(3):343–352.
Simões LR, Maciel GM, Brandão GC, Kroon EG, Castilho RO, Oliveira AB. Antiviral activity of Distictella elongata. Lett Appl Microbiol. 2011;53(6):602–607.
Bhat S, Gething PW, Brady OJ, et al. The global distribution and burden of dengue. Nature. 2013;496(7446):504–507.
Alagarasu K, Bachal RV, Shah PS. Dengue virus infection: Molecular mechanisms, immune responses, and pathogenesis. J Clin Exp Hepatol. 2021;11(3):302–314.
Chambers TJ, Hahn CS, Galler R, Rice CM. Flavivirus genome organization, expression, and replication. Annu Rev Microbiol. 1990;44:649–688.
Bartenschlager R, Miller S. Molecular aspects of dengue virus replication. Future Microbiol. 2008;3(2):155–165.
Bin Masri MF, Rathore APS, St. John AL. Therapeutics for dengue. Curr Treat Options Infect Dis. 2019;11(3):199–214.
Xie X, Zou J, Shi PY. Dengue virus NS5 protein as a target for drug discovery. Antiviral Res. 2017;137:38–47.
Murphy BR, Whitehead SS. Immune response to dengue virus and prospects for a vaccine. Annu Rev Immunol. 2011;29:587–619.
Halstead SB. Dengue. Lancet. 2002;370(9599):1644–1652.
Noisakran S, Perng GC. Alternate hypothesis on the pathogenesis of dengue hemorrhagic fever (DHF). Ann N Y Acad Sci. 2009;1171:E1–E9.
Guzman MG, Istúriz RE. Update on dengue diagnosis, treatment, prevention, and control. Am J Trop Med Hyg. 2010;82(4):587–592.
Tricou V, Minh NN, Farrar J, et al. A randomized controlled trial of chloroquine for the treatment of dengue in Vietnamese adults. PLoS Negl Trop Dis. 2010;4(8):e785.
Nguyen NM, Tran CN, Phung LK, et al. A randomized, double-blind placebo-controlled trial of balapiravir in adult dengue patients. J Infect Dis. 2013;207(9):1442–1450.
Senthilvel P, Lavanya P, Kumar KM, Swathi P. Bioinformatics approach for anti-dengue drug discovery using Carica papaya leaf compounds. Int J Bioinform Res. 2013;5(2):327–332.
Madushanka DMP, Abeysinghe PD, Silva GN. Molecular docking and dynamics simulation studies of phytochemicals from Carica papaya against dengue virus proteins. J Mol Model. 2022;28(3):1–15.
Mishra S, Pandey A, Tiwari R. Molecular docking analysis of phytochemicals from Indian medicinal plants against dengue virus proteins. J Biomol Struct Dyn. 2022;40(22):10879–10892.
Kaushik A, Kumar S, Singh A. In silico and in vitro evaluation of andrographolide against dengue virus NS5 protein. J Biomol Struct Dyn. 2021;39(17):6403–6415.
Ali-Seyed M, Vijayaraghavan K. Dengue virus infections and anti-dengue virus activities of Andrographis paniculata. Asian Pac J Trop Med. 2020;13(2):49–55.
Mandal SC, Sharma S, Karmakar I. Plant-based antivirals and network pharmacology approaches for dengue management. J Ethnopharmacol. 2022;294:115–127.
Subenthiran S, Choon TC, Cheong KC, et al. Carica papaya leaves juice significantly accelerates the rate of increase in platelet count among patients with dengue fever. Evid Based Complement Alternat Med. 2013;2013:616737.
Sharma N, Mishra KP, Chanda S, et al. Evaluation of anti-dengue activity of Carica papaya leaf extract. J Ethnopharmacol. 2019;238:111857.
Tewari D, Jain GK, Kumar A. A systematic review and meta-analysis of some traditional Indian remedies against dengue. Discov Med. 2024;1:39–48.
Lim XY, Chan JS, Japri N, Lee JC, Tan TY. Carica papaya leaf: A systematic scoping review on biological safety and herb–drug interactions. Evid Based Complement Alternat Med. 2021;2021:5511221.
Balkrishna A, Pokhrel S, Singh J, Varshney A. Immunomodulatory and antiviral properties of Tinospora cordifolia (Giloy) in infectious diseases. J Ayurveda Integr Med. 2020;11(4):611–617.
Singh N, Yadav SS. Anti-dengue therapeutic potential of Tinospora cordifolia and its bioactives. J Ethnopharmacol. 2024;326:118242.
Edwin ES, Venkatesh K, Rajan M. Anti-dengue efficacy of andrographolide from Andrographis paniculata against Aedes aegypti. Acta Trop. 2016;163:167–178.
Ling APK, Chye SM, Koh RY, Pui LP. Anti-dengue activity of methanolic extracts of Ocimum tenuiflorum. BMC Complement Altern Med. 2014;14:113.
Tang LI, Ling APK, Koh RY, Chye SM. Traditional Chinese medicine in dengue treatment: Molecular and clinical perspectives. J Tradit Complement Med. 2018;8(1):89–98.
Su CH, Lin YS, Chen YC. Assessing traditional Chinese medicines for anti-dengue activity using national health databases. Food Sci Nutr. 2025;13(1):e10456.
Aschale Y, Yismaw G, Gidey M. Ethnobotanical study of medicinal plants used for the treatment of human ailments in Ethiopia. J Ethnobiol Ethnomed. 2021;17(1):1–17.
Berlian G, Mulyaningsih S, Santoso B. Anti-dengue activity of Euphorbia hirta and Psidium guajava extracts. Asian Pac J Trop Biomed. 2017;7(12):1090–1096.
Cordero JA, Gonzales RJ. Medicinal plants used for dengue treatment: Ethnopharmacology and molecular insights. Front Pharmacol. 2024;15:1039183.
Published
How to Cite
Issue
Section
Copyright (c) 2026 Mohammed Anas, Farhat Jahan
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright Policy & Licensing terms | Tropical Journal of Pharmaceutical and Life Sciences
